Evonik and IMCD are pleased to announce that they have reached an agreement on the distribution of Evonik’s range of sodium and potassium alkoxides in UK, Ireland, Nordics, France, Spain, Portugal, and The Netherlands. 

From June 1, 2020, IMCD, a leading distributor of specialty chemicals and food ingredients, will distribute the materials into industrial and pharmaceutical markets, supporting existing customers and growing the business further. Omega 3 markets are not included in the agreement.

Alexander Weber, Vice President Alkoxides & Potassium Derivatives, Business Line Functional Solutions commented: ‘We are delighted to announce this new distribution partnership – which combines the strength of both parties as leaders in the speciality chemicals sector.

The combination of Evonik’s focus on innovation and state-of-the-art product quality and services, coupled with IMCD’s commitment to technically driven sales and customer proximity form a solid foundation for the future of this partnership and the success of both companies’. 

Chris Young, Director, Regulated Synthesis added: ‘We are extremely pleased to be working with Evonik, the global leader in sodium and potassium alkoxides. IMCD’s in-depth knowledge of the pharmaceutical and industrial synthesis markets will enable us to serve well the existing customers as well as allowing opportunities to grow the business for this key range of products.

IMCD will market the full range of sodium and potassium alkoxides offered by Evonik. These products form an important chemical substance category, used in a wide variety of reactions and applications. The alkoxides can be used as both reagents and catalysts in applications and markets including pharma & healthcare, flavours & additives, and industrial chemical manufacturing.

Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €13.1 billion and an operating profit (adjusted EBITDA) of €2.15 billion in 2019. Evonik goes far beyond chemistry to create innovative, profitable and sustainable solutions for customers. More than 32,000 employees work together for a common purpose: We want to improve life today and tomorrow.

The IMCD Group is a global market-leader in the sales, marketing and distribution of speciality chemicals and food ingredients. Its result-driven professionals provide market-focused solutions to suppliers and customers across EMEA, Americas and Asia-Pacific, offering comprehensive product portfolios ranging from home, industrial and institutional care, personal care, food & nutrition and pharmaceuticals to lubricants & fuels, coatings and construction, advanced materials and synthesis.

The IMCD Group realised revenues of EUR 2,690 million in 2019 with nearly 3,000 employees in over 50 countries. IMCD's dedicated team of technical and commercial experts work in close partnership to tailor best in class solutions and provide value through expertise for around 49,000 customers and a diverse range of world class suppliers. IMCD shares are traded at Euronext, Amsterdam (IMCD).


Back to top

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.